You may subscribe to this RSS feed.
Registered Facilities Database
An updated facility identification database is now available to licensed facilities. The database contains the names and locations of all ICCBBA registered facilities worldwide and their assigned facility identification numbers. It is available both as an Excel file (collection_facilities.xls) and as a tab delimited Text file (collection_facilities.txt). Both documents are available in the password-protected area of the web site. Amendments to entries in these tables should be notified to the ICCBBA office. (For US facilities registered and/or licensed with the FDA, the name and location of your facility should match what appears on your FDA registration or license.) View it here.
09 May 2012
Product Description Code Database Version 4.11.0
Version 4.11.0 of the ISBT 128 Product Description Code Database is now available to licensed facilities here. Updates are listed in the version control sheet. The new database can be downloaded as an Access database or as Text file tables.
09 May 2012
US Consensus for Cellular Therapy Draft v 1.2.0
ICCBBA has made the US Consensus for Cellular Therapy Draft v 1.2.0 available for public comment. ICCBBA will accept comments until June 22, 2012. Send comments to ICCBBA via email at tech.director@iccbba.org.
View the draft here.
07 May 2012
New Blood Documents Available for Public Comment
ICCBBA has made two new draft documents availble. These are intended to replace the Blood Product Code Structure and Labeling Document.
1) ISBT 128 Standard Labeling of Blood Components
This will in part replace labeling aspect of the Product Code Structure and Labeling Document.
2) Use of Product Code Data Structure [003] - Blood Components
This will in part replace the Product Code Structure aspect of the Product Code Structure and Labeling Document.
These documents will be availble for public comment until May 4, 2012. Comments should be sent to tech.director@iccbba.org
New Translations for Introductory Booklets
ICCBBA has published additional translations for our introductory booklet ‘ISBT 128 for Blood, Cells, and Tissue.’ This booklet is now available in the following languages:
- العربية (Arabic)
- 中國 (Chinese)
- Português (Portuguese)
- Русский (Russian)
- Español (Spanish)
The General ISBT 128 booklet is now available in Español (Spanish)
View the documents here.
20 March 2012
New International Cellular Therapy Documents on ISBT 128 Product Code Data Structure and Labeling Products
ICBBA have release two documents to replace the Product Code Structure and labeling document.
1) ISBT 128 Standard Labeling-
This document provides a labeling guideline for ISBT 128 Cellular Therapy products.
view it here.
2) Use of Product Code Data Structure [003]
The purpose of this document is to provide detailed information about ISBT 128 product coding for Cellular Therapy Products. Specifically, it explains:
• the Product Code Data Structure [003] in detail,
• the structure of the data base that supports the product description code,
• how to select an appropriate product description code, and
• how to request new product description codes.
view it here.
WMDA Position Paper Status
The World Marrow Donor Association (WMDA) has posted a position paper discussing how to handle facility confidentiality when labeling Cellular Therapy products from unrelated donors.
In this paper the "WMDA encourages the efforts to adapt ISBT 128 as an effective bar-coded information coding system that supports a globally unique identity,standardized product coding and full traceability of cellular therapy products."
See the position paper here:
12 August 2011
Technical Specification v4.1.0 is available
The newest version of the Technical Specification is now available.
View the document here.
A major change in this version of the Technical Specification is the retirement of Data Structures 015 and 016 that were used to code HLA genomic types. This was needed because of the increased number of characters needed to encode these genotypes. A link to a reference table is provided to ensure backward compatibility for products labeled with these data structures.
21 December 2011
WHO/ICCBBA Standardization of Organ Nomenclature Globally (SONG) Project Report
The World Health Organization has published the report of the first meeting of the WHO/ICCBBA Standardization of Organ Nomenclature Globally (SONG) Project held 4-5 May 2011 in Geneva.
View the report here.
The report is accompanied by a preliminary draft nomenclature which provides an outline structure on which the more detailed terms and definitions will be built.
View the draft nomenclature here.
Comments are welcomed and should be forwarded to Dr Luc Noel at the World Health Organization (noell@who.int).
21 November 2011
2012 Annual License Fee Update
License Fees for 2012 have now been published. Click here for an explanation of the changes to fees, and here to access the updated fee page.
11 November 2011
GS1 Patient Identification Mid-Term Report Available for Public Comment
GS1 is an international not-for-profit association that manages a supply chain coding system. ICCBBA has been working with GS1 and other organizations to create a standard for patient and care-giver identification. The mid-term report from the group is now available for comment. Please respond to questions in the report by entering them into the appropriate fields at the end of the report and clicking on “Submit Form” by September 30, 2011. Alternatively, send comments to techdir@isbt128.org
View the report here.
ACBSA Recommends FDA Create a Task Force to Identify Ways to Promote Standardized Systems for Organ Transplant
The US Advisory Committee on Blood Safety and Availability (ACBSA) has made a number of recommendations to the FDA to improve Organ transplant safety. One of their recommendations was to:
“Identify ways to promote adoption of standardized systems (e.g., ISBT 128) for identification and codification of all organ transplants (including country of origin for those acquired abroad) to facilitate tracking and traceability."
View the letter here.
22 August 2011
WBMT letter to the European Commission Supporting ISBT 128 for Cellular Therapy
The World Network for Blood and Marrow Transplantation” has submitted a letter to the European Commission (EC) supporting ISBT 128 for Cellular Therapy products and recommending that the EC provide a clear indication that the implementation of ISBT 128 for cellular therapy products will be compatible with the European Coding System
See the WBMT letter to the European Commission here: http://www.wbmt.org/
12 August 2011
ICCBBA Presents “One World Award” to Dr. Clive Hohberger
ICCBBA has presented Dr. Clive Hohberger with its One World Award. The One World Award recognizes international efforts to standardize information management for blood, tissue, cellular therapies, and organs.
The presentation by Dr. Jørgen Georgsen, Vice Chairman of the Board of Directors of ICCBBA, took place at the annual AABB meeting in San Diego, CA on October 24, 2011.
To view the full press release click here.